Torrent Pharmaceuticals Ltd.

BSE: TORNTPHARM500420ISIN INE685A01028

Healthcare
Pharmaceuticals
BSE 200

Share price

₹4,730.00+95.00 (+2.05%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹5,249.95
52W low: ₹3,532.85
Off 52W high: -9.90%
1M return: -0.53%
3M return: -5.36%
6M return: +8.55%
1Y return: +32.24%
20D avg volume: 33,434
50 DMA: ₹4,788.77
200 DMA: ₹4,519.55

Key ratios Consolidated

Market cap: ₹1,79,908 Cr
Current price: ₹4,730.00
52W high / low: ₹5,249.95 / ₹3,532.85
Face value: ₹5.00
P/E: 85.71
P/B: 9.78
EPS (TTM): ₹55.18
Book value / share: ₹483.50
ROE: —
ROCE: 9.10%
Operating margin: —
Net margin: —
Debt / equity: 0.84
Net debt: ₹13,681 Cr
Interest cover: 8.46
Dividend yield: 0.80%
Dividend / share (TTM): ₹38.00
Payout: 68.87%
Cash conversion cycle: 99.4 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	4,979	4,921	4,197	3,303	3,302	3,178	2,959	2,809	2,889	2,859	2,745	2,732
	-10.00	-12.00	-17.00	-13.00	-27.00	37.00	-18.00	33.00	16.00	24.00	31.00	33.00
	4,969	4,909	4,180	3,290	3,275	3,141	2,941	2,842	2,873	2,883	2,776	2,699
	4,222	4,155	3,585	2,466	2,471	2,403	2,252	2,151	2,212	2,227	2,145	2,156
	588.00	609.00	566.00	414.00	382.00	396.00	402.00	370.00	337.00	411.00	410.00	379.00
	593.00	531.00	477.00	422.00	382.00	338.00	416.00	420.00	382.00	313.00	315.00	327.00
	895.00	893.00	788.00	651.00	627.00	605.00	561.00	549.00	543.00	550.00	486.00	496.00
	300.00	305.00	236.00	45.00	48.00	56.00	56.00	57.00	64.00	75.00	80.00	80.00
	609.00	593.00	508.00	206.00	204.00	201.00	201.00	199.00	198.00	197.00	203.00	213.00
	1,194	1,201	1,038	765.00	792.00	767.00	703.00	673.00	729.00	711.00	697.00	670.00
	747.00	754.00	595.00	824.00	804.00	738.00	689.00	691.00	661.00	656.00	631.00	543.00
	-10.00	-21.00	-66.00	-10.00	-13.00	0.00	-24.00	0.00	0.00	0.00	0.00	88.00
	737.00	733.00	529.00	814.00	791.00	738.00	665.00	691.00	661.00	656.00	631.00	631.00
	203.00	167.00	165.00	179.00	200.00	190.00	167.00	188.00	208.00	199.00	182.00	188.00
	534.00	566.00	364.00	635.00	591.00	548.00	498.00	503.00	453.00	457.00	449.00	443.00
	14.05	14.87	11.51	18.77	17.45	16.19	14.71	14.88	13.37	13.51	13.27	13.10
Key metrics
	1,646	1,631	1,273	1,065	1,043	995.00	922.00	947.00	923.00	928.00	914.00	924.00
	33.10%	33.10%	30.30%	32.20%	31.60%	31.30%	31.20%	33.70%	31.90%	32.50%	33.30%	33.80%
	10.70%	11.50%	8.70%	19.20%	17.90%	17.20%	16.80%	17.90%	15.70%	16.00%	16.40%	16.20%
	2.80%	—	2.10%	—	7.60%	—	7.00%	—	—	—	—	—
	50.80%	54.80%	41.80%	17.60%	14.30%	11.20%	7.80%	2.80%	—	—	—	—
	-9.60%	3.30%	-26.90%	26.20%	30.50%	19.90%	10.90%	13.50%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	17,400	13,980	11,516	10,728	9,620	8,508	8,005	7,939	7,673	6,002
	-52.00	-94.00	23.00	58.00	45.00	197.00	57.00	122.00	57.00	299.00
	17,348	13,886	11,539	10,786	9,665	8,705	8,062	8,061	7,730	6,301
	14,428	10,925	8,842	8,522	7,818	6,994	6,536	6,874	6,811	5,370
	2,177	1,758	1,520	1,657	1,480	1,538	1,421	1,377	1,290	1,039
	2,023	1,619	1,531	1,184	1,089	831.00	1,005	923.00	846.00	997.00
	3,227	2,671	2,203	1,984	1,678	1,526	1,440	1,429	1,404	1,135
	886.00	385.00	252.00	354.00	333.00	255.00	358.00	451.00	504.00	308.00
	1,916	1,119	795.00	808.00	707.00	662.00	658.00	654.00	618.00	—
	4,198	3,362	2,816	2,690	2,365	2,108	1,933	2,173	2,066	1,844
	2,920	2,961	2,697	2,264	1,847	1,711	1,526	1,187	919.00	931.00
	-107.00	-89.00	-24.00	88.00	0.00	-485.00	0.00	0.00	-357.00	0.00
	2,813	2,872	2,673	2,352	1,847	1,226	1,526	1,187	562.00	931.00
	714.00	734.00	762.00	696.00	602.00	449.00	274.00	162.00	126.00	253.00
	2,099	2,138	1,911	1,656	1,245	777.00	1,252	1,025	436.00	678.00
	59.20	63.92	56.47	48.94	36.79	45.93	73.98	60.55	25.78	—
Key metrics
	5,615	4,376	3,720	3,514	2,887	2,143	2,542	2,292	1,684	1,239
	32.27%	31.30%	32.30%	32.80%	30.00%	25.20%	31.80%	28.90%	21.90%	20.60%
	12.06%	15.30%	16.60%	15.40%	12.90%	9.10%	15.60%	12.90%	5.70%	11.30%
	—	9.10%	28.50%	—	—	—	—	—	—	—
	42.06%	21.40%	7.30%	11.50%	13.10%	6.30%	0.80%	3.50%	27.80%	—
	-1.92%	11.90%	15.40%	33.00%	60.20%	-37.90%	22.10%	135.10%	-35.70%	—
	—	2,346	1,974	—	—	—	—	—	—	—
	—	1.41	1.35	—	—	—	—	—	—	—
	—	0.84	0.40	—	—	—	—	—	—	—
	—	13,681	2,453	—	—	—	—	—	—	—
	—	99.4	82.0	—	—	—	—	—	—	—
Balance sheet
	—	44,312	14,990	—	—	—	—	—	—	—
	—	9,392	5,623	—	—	—	—	—	—	—
	—	1,117	573.00	—	—	—	—	—	—	—
	—	3,031	1,867	—	—	—	—	—	—	—
	—	3,138	2,541	—	—	—	—	—	—	—
	—	629.00	336.00	—	—	—	—	—	—	—
	—	4,909	3,455	—	—	—	—	—	—	—
	—	2,358	1,820	—	—	—	—	—	—	—
	—	8,343	4,717	—	—	—	—	—	—	—
	—	14,798	3,026	—	—	—	—	—	—	—
	—	3,147	1,834	—	—	—	—	—	—	—
	—	11,651	1,192	—	—	—	—	—	—	—
	—	17,585	7,591	—	—	—	—	—	—	—
Cash flow
	—	3,023	2,585	—	—	—	—	—	—	—
	—	-12,713	-540.00	—	—	—	—	—	—	—
	—	10,151	-2,298	—	—	—	—	—	—	—
	—	677.00	611.00	—	—	—	—	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	4,145	4,158	2,735	2,599	2,762	2,616	2,433	2,377	2,434	2,438	2,143	2,123
	-11.00	21.00	58.00	-8.00	-27.00	5.00	15.00	3.00	7.00	21.00	76.00	11.00
	4,134	4,137	2,793	2,591	2,735	2,611	2,448	2,380	2,427	2,459	2,219	2,112
	3,448	3,453	2,154	1,824	1,916	1,869	1,802	1,729	1,757	1,792	1,689	1,682
	584.00	609.00	380.00	411.00	382.00	394.00	402.00	369.00	337.00	410.00	409.00	376.00
	369.00	277.00	210.00	198.00	186.00	173.00	205.00	211.00	175.00	141.00	168.00	129.00
	669.00	677.00	487.00	479.00	460.00	453.00	416.00	407.00	407.00	406.00	353.00	363.00
	287.00	293.00	225.00	34.00	37.00	45.00	47.00	48.00	54.00	64.00	67.00	69.00
	587.00	575.00	197.00	191.00	189.00	187.00	190.00	191.00	190.00	189.00	195.00	191.00
	947.00	970.00	674.00	584.00	609.00	600.00	570.00	539.00	571.00	550.00	536.00	498.00
	686.00	684.00	639.00	767.00	819.00	742.00	646.00	651.00	670.00	667.00	530.00	430.00
	-10.00	-21.00	-47.00	-10.00	-13.00	0.00	-24.00	—	—	—	—	—
	676.00	663.00	592.00	757.00	806.00	742.00	622.00	651.00	670.00	667.00	530.00	430.00
	178.00	171.00	125.00	180.00	209.00	191.00	148.00	166.00	210.00	198.00	120.00	133.00
	498.00	492.00	467.00	577.00	597.00	551.00	474.00	485.00	460.00	469.00	410.00	297.00
	13.09	12.94	13.80	17.04	17.64	16.28	14.00	14.33	13.60	13.86	12.12	8.78
Key metrics
	1,550	1,531	1,014	982.00	1,032	974.00	859.00	890.00	914.00	920.00	792.00	690.00
	37.40%	36.80%	37.10%	37.80%	37.40%	37.20%	35.30%	37.40%	37.60%	37.70%	37.00%	32.50%
	12.00%	11.80%	17.10%	22.20%	21.60%	21.10%	19.50%	20.40%	18.90%	19.20%	19.10%	14.00%
	2.70%	—	3.80%	—	7.90%	—	6.80%	—	—	—	—	—
	50.10%	58.90%	12.40%	9.30%	13.50%	7.30%	13.50%	12.00%	—	—	—	—
	-16.60%	-10.70%	-1.50%	19.00%	29.80%	17.50%	15.60%	63.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	13,637	10,712	9,682	8,533	7,695	6,742	6,451	6,168	5,762	4,248
	60.00	18.00	32.00	91.00	82.00	204.00	118.00	237.00	382.00	332.00
	13,655	10,730	9,714	8,624	7,777	6,946	6,569	6,405	6,144	4,580
	10,879	7,763	7,080	6,707	6,200	5,480	5,203	5,288	5,209	4,018
	1,984	1,567	1,518	1,652	1,477	1,529	1,421	1,353	1,207	995.00
	1,054	767.00	732.00	548.00	534.00	397.00	399.00	341.00	343.00	353.00
	2,312	1,879	1,636	1,451	1,251	1,098	1,097	1,062	1,014	826.00
	839.00	341.00	213.00	303.00	298.00	236.00	339.00	430.00	481.00	294.00
	1,550	764.00	760.00	761.00	672.00	602.00	610.00	607.00	579.00	384.00
	3,175	2,467	2,230	2,061	1,840	1,636	1,487	1,552	1,590	1,398
	2,776	2,967	2,634	1,917	1,577	1,466	1,366	1,117	935.00	562.00
	-88.00	-70.00	-24.00	—	—	—	—	—	—	—
	2,688	2,897	2,610	1,917	1,577	1,466	1,366	1,117	935.00	562.00
	654.00	705.00	722.00	560.00	525.00	475.00	228.00	178.00	190.00	80.00
	2,034	2,192	1,888	1,357	1,052	991.00	1,138	939.00	745.00	482.00
	56.87	64.75	55.79	40.10	31.07	58.59	67.24	55.46	44.05	—
Key metrics
	5,077	4,002	3,583	2,981	2,547	2,304	2,315	2,154	1,995	1,240
	37.23%	37.40%	37.00%	34.90%	33.10%	34.20%	35.90%	34.90%	34.60%	29.20%
	14.92%	20.50%	19.50%	15.90%	13.70%	14.70%	17.60%	15.20%	12.90%	11.30%
	—	15.30%	28.60%	—	—	—	—	—	—	—
	33.85%	10.60%	13.50%	10.90%	14.10%	4.50%	4.60%	7.00%	35.60%	—
	-3.46%	16.10%	39.10%	29.00%	6.20%	-12.90%	21.20%	26.00%	54.60%	—
	—	2,221	2,128	—	—	—	—	—	—	—
	—	1.25	1.36	—	—	—	—	—	—	—
	—	1.68	0.34	—	—	—	—	—	—	—
	—	14,093	2,442	—	—	—	—	—	—	—
	—	114.5	111.7	—	—	—	—	—	—	—
Balance sheet
	—	25,814	12,842	—	—	—	—	—	—	—
	—	4,891	4,349	—	—	—	—	—	—	—
	—	71.00	105.00	—	—	—	—	—	—	—
	—	2,641	2,171	—	—	—	—	—	—	—
	—	1,526	1,561	—	—	—	—	—	—	—
	—	362.00	266.00	—	—	—	—	—	—	—
	—	3,336	3,132	—	—	—	—	—	—	—
	—	806.00	767.00	—	—	—	—	—	—	—
	—	4,590	2,980	—	—	—	—	—	—	—
	—	14,164	2,547	—	—	—	—	—	—	—
	—	2,702	1,526	—	—	—	—	—	—	—
	—	11,462	1,021	—	—	—	—	—	—	—
	—	8,452	7,592	—	—	—	—	—	—	—
Cash flow
	—	2,731	2,574	—	—	—	—	—	—	—
	—	-12,991	-470.00	—	—	—	—	—	—	—
	—	10,226	-2,104	—	—	—	—	—	—	—
	—	510.00	446.00	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +11.66%
Sales CAGR 5Y: +10.67%
Profit CAGR 3Y: +27.72%
Profit CAGR 5Y: +14.01%
Sales YoY (TTM): +33.85%
Profit YoY (TTM): -3.46%

Consolidated

Sales CAGR 3Y: +13.27%
Sales CAGR 5Y: +11.80%
Profit CAGR 3Y: +19.75%
Profit CAGR 5Y: +11.30%
Sales YoY (TTM): +42.06%
Profit YoY (TTM): -1.92%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 60.78%

Quarter	September 2026	June 2026
Promoter %	60.78%	60.78%

Holder	Type	Holding	Previous	Change
TORRENT INVESTMENTS LIMITED (FORMERLY KNOWN AS TORRENT INVESTMENTS PRIVATE LIMITED)	Promoter	60.78%	60.78%	0.00%
NPS TRUST	Public	2.32%	2.23%	+0.09%
HDFC MUTUAL FUND	Public	1.14%	—	—
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND	Public	1.12%	—	—
KOTAK DEBT HYBRID	Public	1.05%	—	—
ANITA SUDHIR MEHTA	Promoter Group	0.00%	0.00%	0.00%
Torrent Solar Power Private Limited	Promoter Group	0.00%	0.00%	0.00%
Dholpur CGD Private Limited	Promoter Group	0.00%	0.00%	0.00%
Newzone Power Projects Private Limited	Promoter Group	0.00%	0.00%	0.00%
Torrent Urja 19 Private Limited	Promoter Group	0.00%	0.00%	0.00%
Onix-One Enersol Private Limited	Promoter Group	0.00%	0.00%	0.00%
Newzone India Private Limited	Promoter Group	0.00%	0.00%	0.00%
Torrent Urja 13 Private Limited	Promoter Group	0.00%	0.00%	0.00%
Torrent Urja 32 Private Limited	Promoter Group	0.00%	0.00%	0.00%
Torrent Urja 23 Private Limited	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%

Filings & corporate actions

Recent announcements

Change in Corporate Address of KFin (RTA) - w.e.f. 01-Dec-264 Nov 2026 · Company Update / General
Newspaper advertisement in respect of special window for transfer and dematerialisation requests of physical shares4 Nov 2026 · Company Update / Newspaper Publication
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 202629 Oct 2026 · Company Update / Analyst / Investor Meet
Recording Link of Analyst call - Q2 Results23 Oct 2026 · Company Update / Analyst / Investor Meet
Outcome of Board Meeting dated 23-Oct-2623 Oct 2026 · Board Meeting / Outcome of Board Meeting
Results for quarter and half year ended 30-Sep-2623 Oct 2026 · Result / Financial Results
Change in Senior Management Personnel (SMP)16 Oct 2026 · Company Update / Change in Management
Post Quarterly Financial Result Conference call with investors / analyst9 Oct 2026 · Company Update / Analyst / Investor Meet
Intimation of Credit Rating7 Oct 2026 · Company Update / Credit Rating
Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve the Audited Financial ....6 Oct 2026 · Board Meeting / Board Meeting
Disclosure pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations28 Sep 2026 · Company Update / Acquisition
Intimation of Closure of Trading Window Period - Q228 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Schedule of Investor Meets10 Sep 2026 · Company Update / Analyst / Investor Meet
Newspaper advertisement in respect of special window for transfer and dematerialisation of physical shares9 Sep 2026 · Company Update / Newspaper Publication
Outcome of Postal Ballot7 Sep 2026 · AGM/EGM / Postal Ballot
Scrutinizer''s Report on the Postal Ballot7 Sep 2026 · AGM/EGM / Postal Ballot
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201511 Aug 2026 · Company Update / Analyst / Investor Meet
ESG Rating11 Aug 2026 · Company Update / General
Newspaper Advertisement for completion of dispatch of Postal Ballot Notice6 Aug 2026 · Company Update / Newspaper Publication
Notice of Postal Ballot5 Aug 2026 · AGM/EGM / Postal Ballot
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 20264 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of Cessation of Director of the Company1 Aug 2026 · Company Update / Cessation
Recording Link of Analyst call - Q1 Results30 Jul 2026 · Company Update / Analyst / Investor Meet
Change in Senior Management Personnel30 Jul 2026 · Company Update / Change in Management
Outcome of Board Meeting dated 30-Jul-2630 Jul 2026 · Board Meeting / Outcome of Board Meeting
Results for quarter ended 30-Jun-2630 Jul 2026 · Result / Financial Results
Appointment of Shanti Ekambaram as an Independent Director of the Company28 Jul 2026 · Company Update / Change in Management
Receipt of final listing and Trading approval for Equity shares of the Company issued and allotted in terms of Scheme of Amalgamation27 Jul 2026 · Company Update / General
Allotment of Equity shares of the Company to eligible shareholders of J B Chemicals as on Record Date in terms of Scheme of Amalgamation20 Jul 2026 · Company Update / General
Disclosure pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 - Dissolution of Wholly Owned Subsidiary (WOS)17 Jul 2026 · Company Update / General
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - ESG Rating17 Jul 2026 · Company Update / General
Post Quarterly Financial Result Conference call with investors / analyst17 Jul 2026 · Company Update / Analyst / Investor Meet
Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve to consider and approve ....16 Jul 2026 · Board Meeting / Board Meeting
Press Release9 Jul 2026 · Company Update / Press Release / Media Release
Newspaper advertisement in respect of special window for transfer and dematerialisation request of physical shares8 Jul 2026 · Company Update / Newspaper Publication
Amendment to Memorandum of Association8 Jul 2026 · Company Update / Amendments to Memorandum & Articles of Association
Intimation of Effective Date of Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders8 Jul 2026 · Company Update / General
Record date in the matter of Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders7 Jul 2026 · Corp. Action / Record Date
Receipt of Certified copy of final order from the Hon''ble NCLT, Ahmedabad Bench sanctioning Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals ....7 Jul 2026 · Company Update / General
Pronouncement of final order by the Hon''ble National Company Law Tribunal, Ahmedabad Bench sanctioning the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent ....6 Jul 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 9.0000	29 May 2026	29 May 2026	—
Interim Dividend - Rs. - 29.0000	18 Feb 2026	19 Feb 2026	—
Final Dividend - Rs. - 6.0000	20 Jun 2025	20 Jun 2025	—
Interim Dividend - Rs. - 26.0000	31 Jan 2025	1 Feb 2025	—

Board meetings

23 Oct 2026 Board Meeting - Financial Results
30 Jul 2026 Board Meeting - Financial Results